BBVA vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BBVA's Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 3/9, signaling significant operational and balance sheet concerns. Despite this, the bank trades at a reasonable valuation with a P/E of 12.30 below the sector average of 21.13, and offers a solid 3.31% dividend yield supported by a sustainable 39.86% payout ratio. Profitability metrics like a 32.91% profit margin and 18.63% ROE are strong, but negative earnings growth and poor technical trend (10/100) offset these gains. The absence of Altman Z-Score data prevents a full distress risk assessment, but the low Piotroski score demands caution.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
BBVA vs JPM: Head-to-Head Comparison
This page compares Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.